Quick Answer
AVENUE THERAPEUTICS, INC. reported Shares Outstanding of 3.18 million shares for fiscal year 2025.
AVENUE THERAPEUTICS, INC. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 3.18M | +51.0% |
| 2024 | 2.11M | +517.8% |
| 2023 | 341,324 | -92.9% |
| 2022 | 4.77M | +239.5% |
| 2021 | 1.41M | -91.6% |
| 2020 | 16.75M | +0.4% |
| 2019 | 16.68M | +56.4% |
| 2018 | 10.67M | +3.9% |
| 2017 | 10.27M | +215.1% |
| 2016 | 3.26M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 3.18M | +98.5% | +0.0% |
| June 30, 2025 | 3.18M | +167.6% | -0.0% |
| March 31, 2025 | 3.18M | +439.4% | +51.0% |
| December 31, 2024 | 2.11M | +517.8% | +31.5% |
| September 30, 2024 | 1.60M | -82.1% | +34.8% |
| June 30, 2024 | 1.19M | -85.0% | +101.6% |
| March 31, 2024 | 590,188 | -91.4% | +72.9% |
| December 31, 2023 | 341,324 | -92.9% | -96.2% |
- AVENUE THERAPEUTICS, INC. showed an increase of +51.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2016–2025 period, AVENUE THERAPEUTICS, INC.’s shares outstanding has declined by 2.3% (from 3.26 million shares to 3.18 million shares).
- The most recent figure is from AVENUE THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: